ELMD
Electromed, Inc.
NYSE AmericanUSDEQUITY
DELAYED
Last price
39.80
▼ 0.20 (0.50%)
MARKET · —
Price
Open
37.01
Prev close
40.00
Day high
40.72
Day low
39.26
Volume
157.03K
Market cap
—
P/E (TTM)
—
52W range
19.93 – 47.40
Trailing performance
Returnvs SPY
1W
-4.29%
-2.9%
1M
+3.33%
-0.4%
3M
+2.26%
-0.8%
6M
+62.61%
+51.5%
YTD
+35.47%
+23.2%
1Y
+101.17%
+81.2%
3Y
+308.39%
+234.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
41.32
-3.67% from price
SMA 20
41.18
-4.19% from price
SMA 50
41.26
-4.39% from price
SMA 100
35.67
+11.59% from price
SMA 200
31.11
+26.82% from price
EMA 12
40.95
-2.81% from price
EMA 26
41.10
-3.17% from price
EMA 50
40.07
-0.67% from price
RSI (14)
40.5
Neutral
MACD (12,26,9)
-0.15
Hist -0.28
ATR (14)
1.45
3.68% of price
Realised vol 30D
31.9%
Annualised
Bollinger upper
43.30
20, 2σ
Bollinger lower
39.06
20, 2σ
50 / 200 cross
Golden
41.26 vs 31.11
Trend bias
Above 200
+26.82%
Risk profile
Beta vs SPY
0.81
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
31.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.3%
Peak to trough
Max drawdown 5Y
-48.9%
Peak to trough
ATR 14
1.45
3.68% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 8d ago
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates
Zacks · 9d ago
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Business Wire · 11d ago
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
Zacks · 11d ago
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 12d ago
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 16d ago
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
Zacks · 43d ago
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks · 47d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.